2026 PoC Acceleration Program

BE Health Ventures and Taipei Medical University have co-launched the POC (proof of the concept) Program that focuses on product or prototype-ready startups that are looking for traction in the Asian market. Based in Taipei, Taiwan we leverage the unique strengths of our ecosystem to position our accelerator program as the gateway to Asia. Our unparalleled access to hospital facilities, research institutes, investors, healthcare experts and other industry stakeholders help you secure funding and expand your market to Japan, Greater China, and SEA. Taipei Medical University has six world-class hospitals under their management, with a focus on innovation and smart hospitals. Establishing them as an ideal partner for those venturing into the Asian healthcare market.  

[International Market Expansion]
Startups teams participating in the acceleration program could be selected for the opportunity to expand to US and Japan market through our international partners: UCSF Rosenman institute (US) and Premo (Japan). Selected startup teams would have opportunities to connect with key stakeholders and medical institutions in San Francisco and Tokyo.

[Key Acceleration]
NEEDS VALIDATION / HOSPITAL PILOT SITE / CLINICAL IMMERSION / MEDICAL RESOURCE / R&D/ MANUFACTURING / INTELLECTUAL PROPERTY / LEGAL/ REGULATIONS / STAKEHOLDER ENGAGEMENT / REIMBURSEMENTS / FUNDRAISING

[Program Fee]
USD 6,500
Includes full access to clinical support, commercialization guidance, and global exposure.

[Program Highlight]
• Support from more than 100 international mentors (Clinical consultations, Business mentoring, Fundraising advisory)
• Opportunity to be funded up to $35K consultation resources
• TMU performance report, Co-working space (in 2026)
• Courses including overseas market expansion, business model establishment, medical regulations, fund raising, etc.
• Media exposure, 1 corporate visit + product demo, 1:1 pitch deck refinement, Welcome Party, Alumni Party, Demo Day
• Cooperation with the TMU and Show Chwan Health Care System

[Program Progress]
1. Validate: AI Medical Research Center, Need and product validation, Demo Site in Taiwan
2. Refine: Referring data scientist, Assisting data acquire, Preparing strategy to enter major Asian markets, Engaging stakeholders, Developing knowledge of the region
3. Implement: Achieving milestones, IP Strategy, Channel Strategy, Regulatory Strategy, Market Expansion, Investor Data Room
4. Next Stage Funding: Securing inward funding, Road Show, Opportunity to be funded up to 200K

[Focus Area]
• Precision Health: Telehealth, Precision Medicine, Next Generation Sequencing, Smart Hospital
• Artificial Intelligence: Medical Imaging, Auxiliary Diagnosis, Health Management, Drug Discovery
• Medical Device: Advanced Biomaterials, Monitoring & Therapeutics, Delivery Platform, IVD diagnosis

[Timeline]
• Recruiting: From NOW ~ 2026/01/19
• Selection: 2026/01 ~ 2026/02
• Training: 2026/03 ~ 2026/08
• Demo Day: Late 2026/07

For more information: Website (Open in new window)